Deka Bank Deutsche Girozentrale Castle Biosciences Inc Transaction History

Deka Bank Deutsche Girozentrale

  • $53.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022
BUY
$33.17 - $46.98 $23,219 - $32,886
700 Added 9.72%
7,900 $348,000
Q4 2021

Feb 02, 2022
BUY
$39.06 - $67.58 $7,812 - $13,516
200 Added 2.86%
7,200 $296,000
Q4 2020

Mar 12, 2021
BUY
$43.6 - $73.05 $305,200 - $511,350
7,000 New
7,000 $468,000

Others Institutions Holding CSTL

# of Institutions
201
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $724M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email